53 results
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health information privacy and security, and other
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
information privacy and security, and other healthcare laws and regulations;
the effects of competition for our product candidates and the potential for new
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
claims, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our product
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
and abuse, false claims, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our
8-K
EX-99.1
1l16kgom8n
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
424B3
m3lk6y1c71ww622d
2 Feb 24
Prospectus supplement
12:00am
8-K
EX-10.2
zbbtvsl88b0myn8ktr
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
xxcqvl 48
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
1yhlnnzw
5 Oct 23
Free writing prospectus
5:05pm
FWP
5u4th
3 Oct 23
Free writing prospectus
5:47pm
424B3
hlg9frpfdh37
28 Jun 23
Prospectus supplement
4:56pm